Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China flag China · Delayed Price · Currency is CNY
21.25
+0.39 (1.87%)
Aug 4, 2026, 3:04 PM CST

Wuhan Hvsen Biotechnology Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
1,7401,6811,2001,0201,023996.22
Revenue Growth
24.98%40.07%17.71%-0.31%2.68%28.14%
Gross Profit
583.8518.76194.72210.65222.75268.51
Operating Income
323.95279.4718.356.5761.01135.28
Net Income
286.33253.16-20.1616.7852.71132.87
Earnings Per Share
1.421.29-0.120.100.320.80
EPS Growth
487.72%---68.27%-60.25%-21.41%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
East China
408.59316.78288.81331.94336.97
Central China
345.41253.37213.86217.75192.61
South China
251.57209.59186.08202.8211.25
North China
307.65174.97125.285.8776.87
Southwest China
88.4687.986.6489.9486.68
Northwest China
58.5641.741.6539.0533.87
Northeast China
61.152.6252.7243.3645.1
Export
159.9163.3924.7912.212.87
Total
1,6811,2001,0201,023996.22

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
610.25470.53527.11597.87785.721,098
Total Debt
342.05228.6888.56842.24790.45680.98
Net Cash (Debt)
268.2241.93-361.45-244.38-4.72417.47
Net Cash Growth
------41.03%
Net Cash Per Share
1.331.23-2.18-1.47-0.032.52

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
233.11238.4543.5392.9296.68155.72
Capital Expenditures
-129.59-96.92-194.43-184.31-428.87-600.12
Free Cash Flow
103.52141.53-150.89-91.39-332.18-444.4
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
33.54%30.86%16.22%20.66%21.78%26.95%
Operating Margin
18.61%16.62%1.53%0.64%5.96%13.58%
Pretax Margin
18.69%17.17%-2.41%1.22%5.54%15.14%
Profit Margin
16.45%15.06%-1.68%1.65%5.15%13.34%
FCF Margin
5.95%8.42%-12.57%-8.96%-32.48%-44.61%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.4000.3000.1060.2700.3000.331
Dividend Per Share Growth
-3.11%181.91%-60.59%-10.00%-9.37%21.11%
Dividend Yield
1.92%1.46%1.08%1.94%1.55%1.25%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
15.0016.51-140.8963.6835.64
Forward PE
18.8120.5320.9630.4420.96-
P/FCF Ratio
41.4229.53----
PS Ratio
2.462.491.382.323.284.75